Cutler Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$58K Buy
+1,700
New +$61.4K 0.02% 613
2023
Q4
Sell
-300
Closed -$6K 4363
2023
Q3
$6K Buy
+300
New +$6.59K ﹤0.01% 2790
2022
Q3
Sell
-500
Closed -$21.2K 5531
2022
Q2
$17K Hold
500
﹤0.01% 2824
2022
Q1
$24K Buy
500
+100
+25% +$5.54K ﹤0.01% 2906
2021
Q4
$30K Buy
400
+100
+33% +$10.3K ﹤0.01% 2809
2021
Q3
$32K Sell
300
-100
-25% -$11.4K ﹤0.01% 2923
2021
Q2
$53K Sell
400
-419
-51% -$48.7K ﹤0.01% 2439
2021
Q1
$101K Buy
+819
New +$124K 0.01% 1769

Other funds holding TWST

Cutler Group's TWST Position: Q1 2024 in Review

Cutler Group opened a new position in Twist Bioscience (TWST) in Q1 2024: 1,700 shares worth $58K. The stake represents 0.02% of the portfolio and ranks #613 among its holdings. This is a return to the name: Cutler Group previously reported a position in TWST as recently as Q3 2023.

Cutler Group first reported a position in TWST in Q1 2021 and has held it in 8 quarters since. The position peaked at $101K in Q1 2021. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

  • Cutler Group held 1,700 shares of Twist Bioscience worth $58K as of Q1 2024.
  • Twist Bioscience was a new Cutler Group position in Q1 2024.
  • Twist Bioscience made up 0.02% of Cutler Group's portfolio in Q1 2024, its #613 holding.
  • Cutler Group first reported a position in Twist Bioscience in Q1 2021 and has held it in 8 quarters since.
  • Cutler Group's Twist Bioscience position peaked at $101K in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.